SCHEDULE 13G: Statement of Beneficial Ownership by Certain Investors
Published on
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 | |
SCHEDULE 13G | |
UNDER THE SECURITIES EXCHANGE ACT OF 1934
| |
bioAffinity Technologies, Inc. (Name of Issuer) | |
Common Stock (Title of Class of Securities) | |
| |
09/30/2026 (Date of Event Which Requires Filing of this Statement) |
| Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
Rule 13d-1(b)
|
Rule 13d-1(c)
|
Rule 13d-1(d)
|
SCHEDULE 13G
|
| CUSIP Number(s): | 09076W406 |
| 1 | Names of Reporting Persons
HRT FINANCIAL LP | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
127,132.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
![]() | ||||||||
| 11 | Percent of class represented by amount in row (9)
10.9 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
BD |
Comment for Type of Reporting Person: The percentage reported herein is based on 1,166,625 shares of Common Stock outstanding as of
September 30, 2026, as reported by bioAffinity Technologies, Inc. in its Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, filed with the Securities and Exchange Commission on November 6, 2026, plus 986 shares of Common Stock issuable upon the exercise of certain warrants held by HRT Financial LP, for a denominator of 1,167,611 shares.
SCHEDULE 13G
|
| Item 1. | ||
| (a) | Name of issuer:
bioAffinity Technologies, Inc. | |
| (b) | Address of issuer's principal executive offices:
3300 NACOGDOCHES ROAD, SUITE 216, SAN ANTONIO, TEXAS, 78217. | |
| Item 2. | ||
| (a) | Name of person filing:
HRT Financial LP, a Delaware limited partnership | |
| (b) | Address or principal business office or, if none, residence:
c/o Hudson River Trading LLC, 3 World Trade Center, 175 Greenwich Street, 76th Floor, New York, NY 10007 | |
| (c) | Citizenship:
Delaware | |
| (d) | Title of class of securities:
Common Stock | |
| (e) | CUSIP Number(s):
09076W406 | |
| Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: | |
| (a) | Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
| |
| (b) | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
| |
| (c) | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
| |
| (d) | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
| |
| (e) | An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
| |
| (f) | An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
| |
| (g) | A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
| |
| (h) | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
| |
| (i) | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
| |
| (j) | A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution: | |
| (k) | Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
| |
| Item 4. | Ownership | |
| (a) | Amount beneficially owned:
The ownership information reported herein is as of September 30, 2026.
The reported aggregate amount includes 126,146 shares of Common Stock held directly and 986 shares of Common Stock issuable upon the exercise of certain warrants held by the Reporting Person.
The response to Row 9 of the cover page is incorporated herein by reference and sets forth the information required by this item.
| |
| (b) | Percent of class:
The response to Row 11 of the cover page is incorporated herein by reference and sets forth the information required by this item. | |
| (c) | Number of shares as to which the person has:
| |
| (i) Sole power to vote or to direct the vote:
The response to Row 5 of the cover page is incorporated herein by reference and sets forth the information required by this item. | ||
| (ii) Shared power to vote or to direct the vote:
The response to Row 6 of the cover page is incorporated herein by reference and sets forth the information required by this item. | ||
| (iii) Sole power to dispose or to direct the disposition of:
The response to Row 7 of the cover page is incorporated herein by reference and sets forth the information required by this item. | ||
| (iv) Shared power to dispose or to direct the disposition of:
The response to Row 8 of the cover page is incorporated herein by reference and sets forth the information required by this item. | ||
| Item 5. | Ownership of 5 Percent or Less of a Class. | |
Not Applicable
| ||
| Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. | |
Not Applicable
| ||
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. | |
Not Applicable
| ||
| Item 8. | Identification and Classification of Members of the Group. | |
Not Applicable
| ||
| Item 9. | Notice of Dissolution of Group. | |
Not Applicable
| ||
| Item 10. | Certifications: |
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
|
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
Rule 13d-1(b)
Rule 13d-1(c)